Small cell lung cancer is a fast-growing type of lung cancer made up of small, tightly packed neuroendocrine cells. It makes up roughly one in seven lung cancers and is strongly linked to smoking. Asbestos exposure raises the risk of all major types of lung cancer, including small cell.
Origin
Pathologists described this tumor in the early twentieth century; its older name, oat cell carcinoma, comes from the oat-grain shape of the cells under the microscope. It was later recognized as a cancer of neuroendocrine cells, separate from the non-small cell types.
Significance in Asbestos Context
Small cell lung cancer is usually staged as limited (confined to one side of the chest) or extensive, and it often has spread by the time it is found. It typically responds at first to chemotherapy, now often combined with immunotherapy, and radiation is used for limited disease, but it tends to come back. Because it is so strongly tied to smoking, defendants often argue that smoking alone caused it. Medical consensus statements, including the Helsinki criteria, treat asbestos as a cause of lung cancer regardless of cell type, and smoking and asbestos together multiply the risk. Trust lung cancer criteria do not usually depend on the cell type, but the higher-paying level generally requires evidence of asbestosis or bilateral pleural disease, plus qualifying exposure and latency. Most trusts also have a lower lung cancer level (often called Lung Cancer 2) for claims without that evidence; it pays roughly what an asbestosis claim pays, or less. A lawsuit will turn on the exposure evidence and on the medical experts' views on causation.
Example Sentence
The bronchoscopy biopsy showed small cell lung cancer, and his CT also showed bilateral pleural plaques from his years in a shipyard.
Related Terms
Lung Cancer, Non-Small Cell Lung Cancer, Bronchogenic Carcinoma, Helsinki Criteria, Synergistic Effect, Chemotherapy, Atezolizumab (Tecentriq), Smoking Defense
Notes
- Keep the pathology report naming the cancer type.
- Ask your doctors to record any asbestos-related lung or pleural changes they see on your scans.
- Give your lawyer a full work history and smoking history early; both will be examined.
In the research library
49 studies in our medical research library mention Small Cell Lung Cancer in the title or abstract. Among the most cited:
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancerM.C. Crisanti, A.F. Wallace, V. Kapoor, et al, 2009 · Molecular Cancer Therapeutics · cited 104 times
- Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumoursD.W. Dumoulin, P. Bironzo, F. Passiglia, et al, 2023 · European Respiratory Review · cited 11 times
- Role of Immunotherapy in Small Cell Lung Cancer, Thymic Epithelial Tumors, and MesotheliomaC.L. Hann, A. Scherpereel, J.A. Hellyer, et al, 2019 · American Society of Clinical Oncology Educational Book · cited 11 times
- Asbestosis and small cell lung cancer in a clutch refabricatorJ.L. Levin, M.F. O'Sullivan, C.J. Corn, et al, 1999 · Occupational and Environmental Medicine · cited 10 times
- The release of bombesin-like peptides from small cell lung cancer cellsT.W. Moody, L.Y. Korman, 1988 · Annals of the New York Academy of Sciences · cited 8 times
The journals that publish most on it: International Journal of Oncology (2), PloS One (1), Translational Lung Cancer Research (1).
Category: Diseases & Conditions · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.